NeuroVasc
California, US · Founded 2015 · Delaware corporation · 2 known investors
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Founders & leadership
JP
JEFF PETERSDirector
LG
LU GANGDirector
DF
DAVE FERRERADirector
JM
JIANLU MAExecutive Officer, Director
WD
WILLIAM DAIDirector
Investors · 2
Competitors · 9
by search overlapEvtoday31 shared keywords
Innova Vascular26 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Massdevice25 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Diabetes Prevention Program24 shared keywords
Read the Press Release21 shared keywords
Fda19 shared keywords
Boston Scientific19 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis Vascular17 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
EndoSense16 shared keywords
Companies competing with NeuroVasc for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$4.2MraisedMay 2018 · 9 investors · Other TechnologyRule 506(b)
▶$4.2MraisedMay 2018 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jianlu MaExecutive Officer, Director
- James HanDirector
- Michael LosordoExecutive Officer
- William DaiDirector
- Gang LuDirector
- Offering amount
- $6.4M
- Amount sold
- $4.2M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$500KraisedNov 2017 · 3 investors · Other Health CareRule 506(b)
▶$500KraisedNov 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JIANLU MaExecutive Officer, Director
- Gang LuDirector
- William DaiDirector
- Offering amount
- $900K
- Amount sold
- $500K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1MraisedDec 2016 · 3 investors · Other Health CareRule 506(b)
▶$1MraisedDec 2016 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gang LuDirector
- William DaiDirector
- Jeff PetersDirector
- JIANLU MaExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.4MraisedNov 2015 · 4 investors · Other Health CareRule 506(b)
▶$1.4MraisedNov 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JEFF PETERSDirector
- LU GANGDirector
- DAVE FERRERADirector
- WILLIAM DAIDirector
- JIANLU MAExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $1.4M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- NeuroVasc’s $34M Funding China-Backed - Orange County Business Journalocbj.com · 2020
- NeuroVasc Tech raises $6m in Series B - MassDevicemassdevice.com · 2018
- NeuroVasc Technologies, Inc. closes Series B financing of $6.3MMprnewswire.com · 2018
- Stealthy NeuroVasc Technologies raises $1m - MassDevicemassdevice.com · 2016